Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01870752 · ClinicalTrials.gov registry record · NA
Ovarian Tissue Transplantation
A NA study of Infertile Females or Females With Ovarian Insufficiency, sponsored by Abramson Cancer Center at Penn Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT01870752: Recruiting NA study of Infertile Females or Females With Ovarian Insufficiency, sponsored by Abramson Cancer Center at Penn Medicine.
NCT01870752 is a NA study of Infertile Females or Females With Ovarian Insufficiency that is actively recruiting participants, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01870752, a NA study of Infertile Females or Females With Ovarian Insufficiency, is actively recruiting participants, sponsored by Abramson Cancer Center at Penn Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Chemotherapy and radiation therapy for the treatment of cancer can compromise fertility. Ovarian tissue cryopreservation is an experimental strategy offered at The University of Pennsylvania to preserve future fertility (protocol 806062). The primary objective of this study is to determine the efficacy and safety of autologous transplantation of previously cryopreserved ovarian cortical tissue in patients who experience infertility or ovarian insufficiency after cancer treatments.
Conditions Studied
Interventions
- PROCEDURE Transplantation of previously cryopreserved ovarian tissu
Study Locations (1)
Pennsylvania
- Abramson Cancer Center of the University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-06 |
| Est. Completion | 2028-12 |
| Phase | NA |
What NCT01870752 shows while recruiting
NCT01870752 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Infertile Females or Females With Ovarian Insufficiency appearing as the primary indexed condition, and to 1 intervention - of which Transplantation of previously cryopreserved ovarian tissu is the first listed.
NCT01870752 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01870752 about?
NCT01870752 is a clinical study titled "Ovarian Tissue Transplantation". Chemotherapy and radiation therapy for the treatment of cancer can compromise fertility. Ovarian tissue cryopreservation is an experimental strategy offered at The University of Pennsylvania to preserve future fertility (protocol 806062). The primary objective of this study is to determine the effic...
What is the current status of trial NCT01870752?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2013-06. Estimated completion is 2028-12.
What conditions does trial NCT01870752 study?
This clinical trial studies the following conditions: Infertile Females or Females With Ovarian Insufficiency.
What interventions are being tested in trial NCT01870752?
The interventions under investigation include: Transplantation of previously cryopreserved ovarian tissu (PROCEDURE).
Who is sponsoring clinical trial NCT01870752?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01870752 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01870752's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia